Literature DB >> 9810213

[Pharma-clinics. Doping with erythropoietin or the misuse of therapeutic advances].

A J Scheen1.   

Abstract

Sport performance depends on the capacity of oxygen transport to the exercising skeletal muscles. Performance may be increased thanks to an haematocrit augmentation, either by training in high altitude, using blood transfusions, or injecting erythropoietin (Epo). Since the synthesis of Epo by bioengineering, doping with recombinant human Epo has become popular in sports in general, and in cycling in particular. This new kind of doping might have been responsible for several sudden deaths in young athletes, essentially in racing cyclists. Until now, such a doping is hardly to be detected. However, it should deserve careful consideration from both public health authorities and sports communities in order to stop what could become a real plague.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9810213

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  3 in total

Review 1.  Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.

Authors:  Emmanuelle Varlet-Marie; Aurélie Gaudard; Michel Audran; Francoise Bressolle
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

2.  Philosophy on steroids: why the anti-doping position could use a little enhancement.

Authors:  Brent M Kious
Journal:  Theor Med Bioeth       Date:  2008-10-22

Review 3.  Haemorheology in exercise and training.

Authors:  Mahmoud S El-Sayed; Nagia Ali; Zeinab El-Sayed Ali
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.